| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.58B | -1.8% | +25.3% |
| R&D Expense | $41.0M | — | -40.6% |
| SG&A Expense | $302.0M | — | +10.6% |
| Operating Income | $904.0M | +27.9% | +48.4% |
| Interest Expense | $188.0M | — | +8.0% |
| Pre-tax Income | $748.0M | — | +58.8% |
| Income Tax | $107.0M | — | +69.8% |
| Net Income | $567.0M | +43.5% | +61.1% |
| EPS (Basic) | $0.85 | +44.1% | +73.5% |
| EPS (Diluted) | $0.85 | +46.6% | +73.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.33B | -13.3% | +9.7% |
| Accounts Receivable | $677.0M | -8.8% | +55.6% |
| Inventory | $46.0M | +0.0% | +12.2% |
| Current Assets | $4.27B | -11.7% | +14.6% |
| Total Assets | $21.18B | -3.4% | -0.3% |
| Current Liabilities | $4.63B | +9.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $731.0M | — | +39.0% |
| Capital Expenditures | $194.0M | — | -48.8% |
| Investing Cash Flow | -$186.0M | — | +59.0% |
| Financing Cash Flow | -$1.04B | — | -50.3% |
| Free Cash Flow | $537.0M | — | +265.3% |
| -25.9% |
| Long-term Debt | $13.90B | -5.2% | +28.0% |
| Total Liabilities | $19.57B | -2.1% | +7.4% |
| Stockholders' Equity | $1.20B | -24.7% | -55.6% |